Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed Sells 29,031 Shares

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 29,031 shares of the stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $0.81, for a total transaction of $23,515.11. Following the sale, the chief financial officer now directly owns 279,901 shares of the company’s stock, valued at approximately $226,719.81. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Nabeel Ahmed also recently made the following trade(s):

• On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total value of $2,367.15.
• On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total value of $3,376.80.

Outset Medical Stock Down 6.1 %

Shares of NASDAQ:OM opened at $0.76 on Thursday. Outset Medical, Inc. has a 52 week low of $0.44 and a 52 week high of $5.22. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49. The company has a market cap of $40.06 million, a PE ratio of -0.28 and a beta of 2.05. The firm has a 50 day simple moving average of $1.01 and a 200 day simple moving average of $1.39.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $3.00 target price on shares of Outset Medical in a report on Tuesday, January 7th.

Institutional Trading of Outset Medical

Hedge funds have recently modified their holdings of the business. National Bank of Canada FI raised its position in Outset Medical by 79.2% during the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after buying an additional 23,164 shares during the period. Huntington National Bank grew its stake in Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after acquiring an additional 20,000 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Outset Medical in the 2nd quarter valued at about $49,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Outset Medical in the second quarter worth approximately $259,000. Finally, Squarepoint Ops LLC boosted its holdings in shares of Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after purchasing an additional 34,187 shares during the period.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.